CARsgen Therapeutics Email Format

Biotechnology ResearchShanghai, China51-200 Employees

CARsgen Therapeutics is a biopharmaceutical company that conducts biotechnology research with operations in China and the United States. The company focuses on developing CAR T-cell therapies for hematologic malignancies and solid tumors. It has built an integrated cell therapy platform with in-house capabilities spanning target discovery, antibody development, clinical trials, and commercial-scale manufacturing. Its product pipeline leverages internally developed technologies and holds global rights aimed at improving safety, efficacy in solid tumors, and reducing treatment costs. The company is headquartered in Shanghai, China, at 1f Building 2 No.466 Yindu Road, Shanghai 200231, and employs 51-200 people. Public disclosures indicate revenue in the range of $50M-$100M and total funding of about $186M.

Sign up for free to view info

Company overview Employee directory